進階篩選

Technical category
    • 變種冠狀病毒蛋白晶片:疫情與後疫情時代之應用

      Precision Health Ecosystem FutureTech 變種冠狀病毒蛋白晶片:疫情與後疫情時代之應用

      Due to the recent outbreak of COVID-19ongoing mutants, we developed a coronavirus variant protein microarray that includes all the current spike mutationsthe wild-type viral antigensapplied in detecting immune responsesdrug specificities. We filed the patientspublished our findings in the Analytical Chemistry. Besides massive production of the coronavirus protein microarray, we also collaborated with a scanner company, developed artificial intelligence software,collaborated with suppliers. We are welcome any sort of collaboration.
    • 全方位血液細胞影像與生化分析系統

      FutureTech 全方位血液細胞影像與生化分析系統

      Our system is achieved by integrating diffractiondeep learning methods, which allows high-throughput lensless imaging system to display wide rangehigh-resolution images. In addition, the developed extraction chipsprototype were verified to accurately detect the numberproportion of blood cells under low blood demand. Our system shows great potential in point-of-care blood cells monitoring for cancer patients that could reduce infection riskmortality rate, increase efficacy of chemotherapysupport precision medicine.
    • Ultra-Efficient Microfluidic Sperm Sorter

      Medical Devices FutureTech Ultra-Efficient Microfluidic Sperm Sorter

      We developed a new type of microfluidic chip with utilizing the characteristic of sperm anadromous instinct for high-throughput sperm separation. The process can be finished in 10 min, which is 10 times faster than the conventional design. Experiment reveals that the qualified sperm motility was raised up from 30 to 99linearity (LIN) up from 0.2 to 0.85 via sorting by our microfluidic chip.
    • 精子快篩晶片

      FutureTech 精子快篩晶片

      Infertility is a serious globe issue, especially in the developed countries, over 20%infertile male has sperm problems, that include instance immotile, abnormal morphology and low sperm quantity. Therefore, how to isolate high quality sperm for clinical use is extremely required. Up to date, activity sperm sorting is usually using Swiming-up and Density gradient centrifugation approaches. Unfortunately, both methods are detrimental to the sperm viability and elicits production of reactive oxygen species. Separation sperm by microfluidics has been put emphasis on and studied; however, it faced some challenge such as low throughput and an unacceptable recover rate.
    • 珍珠號-低軌通訊實驗立方衛星

      FutureTech 珍珠號-低軌通訊實驗立方衛星

      PEARL is a 6U CubeSat with a Ku/Ka-band Communication Payload (KCP) to provide a high throughput satellite communication networka CIP to monitor connection quality of global satellite communicationsoutage of navigation signals.
    • 生物製造之癌症晶片應用於患者特異性用藥預測平台

      FutureTech 生物製造之癌症晶片應用於患者特異性用藥預測平台

      The key technology of Patient Derived Tumor Spheroids (PDTS) is to create an in-vitro patient tumor microenvironmenttumor-like properties, furthermore, predict various cancer antidrug effectiveness to each patient via the high-throughputhigh-quality cell viability detectionbiomarker analysis. Therefore, this project established several technologies including extracellular matrix fabrication, bioink design, cell population identification,tumor physiological environment for the upon goal.
    • Develop of novel anti-diabetic agents via targeting endogenous lipid mediators

      Bio-tech & New Drugs FutureTech Develop of novel anti-diabetic agents via targeting endogenous lipid mediators

      PPARγ is the master regulator of glucose metabolism.15-keto-PGE2 is an endogenous PPARγ ligand whitch is degraded by ZADH1. We found that increasing 15-keto-PGE2 promotes glucose uptake. We identified several ZADH1 inhibitors which could increase 15-keto-PGE2 promote glucose uptake via activating PPARγ. Our results showed that inhibition of ZADH1 is a novel approach to treat type 2 diabes mell
  • 1